0000899243-22-026840.txt : 20220727 0000899243-22-026840.hdr.sgml : 20220727 20220727161744 ACCESSION NUMBER: 0000899243-22-026840 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220725 FILED AS OF DATE: 20220727 DATE AS OF CHANGE: 20220727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 221111228 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-25 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 Executive Chairman Common Stock 2022-07-25 4 M 0 60342 91.05 A 134502 D Common Stock 2022-07-25 4 S 0 13869 279.44 D 120633 D Common Stock 2022-07-25 4 S 0 32983 280.37 D 87650 D Common Stock 2022-07-25 4 S 0 34090 281.27 D 53560 D Common Stock 2022-07-25 4 S 0 40666 282.43 D 12894 D Common Stock 2022-07-25 4 S 0 10471 283.42 D 2423 D Common Stock 440 I 401(k) Stock Option (Right to Buy) 91.05 2022-07-25 4 M 0 60342 0.00 D 2026-02-01 Common Stock 60342 33524 D Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89). Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88). Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89). Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89). Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84). Fully vested. /s/ Joy Liu, Attorney-in-Fact 2022-07-27